KBIO LABS Inc. (KOSDAQ:038530)
South Korea · Delayed Price · Currency is KRW 929.00
+2.00 (0.22%)
At close: Jun 17, 2026
KBIO LABS Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 82,639 | 87,312 | 76,514 | 27,325 | 31,129 | 8,722 |
Other Revenue | - | - | - | - | -0 | - |
| 82,639 | 87,312 | 76,514 | 27,325 | 31,129 | 8,722 | |
Revenue Growth (YoY) | 2.01% | 14.11% | 180.02% | -12.22% | 256.89% | 52.80% |
Cost of Revenue | 71,256 | 74,795 | 64,854 | 23,730 | 27,457 | 6,823 |
Gross Profit | 11,383 | 12,517 | 11,660 | 3,595 | 3,671 | 1,899 |
Selling, General & Admin | 8,574 | 8,564 | 8,257 | 3,695 | 3,001 | 5,986 |
Research & Development | 1,333 | 1,321 | 1,132 | - | - | - |
Amortization of Goodwill & Intangibles | 19.89 | 19.94 | 255.52 | 333.9 | 333.9 | 58.35 |
Other Operating Expenses | 236.78 | 224.22 | 273.27 | 65.02 | 80.58 | 150.43 |
Operating Expenses | 11,763 | 11,761 | 12,770 | 4,212 | 3,218 | 6,986 |
Operating Income | -379.93 | 755.63 | -1,110 | -616.78 | 453.41 | -5,087 |
Interest Expense | -49.63 | -53.95 | -78.02 | -60.82 | -1,207 | -1,781 |
Interest & Investment Income | 1,608 | 1,647 | 1,843 | 838.47 | 995.31 | 929.97 |
Currency Exchange Gain (Loss) | 665.26 | -133.92 | 995.81 | 0.75 | -2.26 | -0.32 |
Other Non Operating Income (Expenses) | 3.09 | 5.77 | 198.19 | 16,366 | -1,457 | 58.91 |
EBT Excluding Unusual Items | 1,847 | 2,220 | 1,849 | 16,527 | -1,217 | -5,880 |
Gain (Loss) on Sale of Investments | -4,456 | -7,094 | -7,820 | -28,301 | -5,757 | -10,705 |
Gain (Loss) on Sale of Assets | 2.73 | 4.48 | 0.79 | -26.74 | 14.28 | - |
Asset Writedown | -12.01 | -12.01 | -3,890 | - | -54.46 | - |
Other Unusual Items | - | - | - | -17.45 | - | - |
Pretax Income | -2,619 | -4,881 | -9,861 | -11,817 | -7,015 | -16,585 |
Income Tax Expense | 162.07 | 162.07 | 132.3 | - | - | - |
Earnings From Continuing Operations | -2,781 | -5,043 | -9,993 | -11,817 | -7,015 | -16,585 |
Earnings From Discontinued Operations | - | - | - | -857.05 | -650.4 | -2,881 |
Net Income to Company | -2,781 | -5,043 | -9,993 | -12,674 | -7,665 | -19,466 |
Minority Interest in Earnings | 441.35 | 1,844 | 3,202 | - | - | - |
Net Income | -2,340 | -3,200 | -6,791 | -12,674 | -7,665 | -19,466 |
Net Income to Common | -2,340 | -3,200 | -6,791 | -12,674 | -7,665 | -19,466 |
Shares Outstanding (Basic) | 26 | 23 | 23 | 20 | 18 | 15 |
Shares Outstanding (Diluted) | 26 | 23 | 23 | 20 | 18 | 15 |
Shares Change (YoY) | -43.26% | 0.34% | 12.65% | 12.29% | 17.81% | 737.44% |
EPS (Basic) | -89.93 | -138.51 | -295.00 | -620.16 | -421.16 | -1260.03 |
EPS (Diluted) | -89.93 | -138.51 | -295.00 | -621.94 | -421.16 | -1261.50 |
Free Cash Flow | 7,910 | 8,160 | -190.34 | -1,471 | 3,768 | -1,213 |
Free Cash Flow Per Share | 304.02 | 353.27 | -8.27 | -71.98 | 207.05 | -78.51 |
Gross Margin | 13.78% | 14.34% | 15.24% | 13.16% | 11.79% | 21.77% |
Operating Margin | -0.46% | 0.86% | -1.45% | -2.26% | 1.46% | -58.33% |
Profit Margin | -2.83% | -3.67% | -8.88% | -46.38% | -24.62% | -223.18% |
Free Cash Flow Margin | 9.57% | 9.35% | -0.25% | -5.38% | 12.11% | -13.91% |
EBITDA | 564.57 | 1,693 | -25.92 | -125.74 | 1,045 | -4,413 |
EBITDA Margin | 0.68% | 1.94% | -0.03% | -0.46% | 3.36% | -50.60% |
D&A For EBITDA | 944.5 | 937.55 | 1,084 | 491.03 | 591.58 | 674 |
EBIT | -379.93 | 755.63 | -1,110 | -616.78 | 453.41 | -5,087 |
EBIT Margin | -0.46% | 0.86% | -1.45% | -2.26% | 1.46% | -58.33% |
Advertising Expenses | - | 51.26 | 45.94 | 4 | 0.93 | 1,087 |